Items related to Ru-486, Status Report on the U. S. Commercialization...

Ru-486, Status Report on the U. S. Commercialization Project, Transfer of Antiprogestin Technology to the United States: Hearing Before the ... the Committee on Small Business, House of Rep - Softcover

U. S. Committee On Small Business

 
9781334788680: Ru-486, Status Report on the U. S. Commercialization Project, Transfer of Antiprogestin Technology to the United States: Hearing Before the ... the Committee on Small Business, House of Rep

Synopsis

This book records the proceedings of a 1994 subcommittee hearing regarding the commercialization of the drug RU-486 in the United States. The book contextualizes the hearings by describing the social and political battles that had been waged in the United States over reproductive rights, including earlier attempts by the Bush administration to suppress RU-486. The book follows the testimony of Roussel-Uclaf, the maker of RU-486, and the Population Council, a non-profit foundation; both entities had been lobbying the FDA to approve the sale of RU-486 in the US. The book gives a blow-by-blow account of the hearings, delving into the scientific data regarding RU-486's safety and efficacy and laying bare the complexities of the drug's potential political uses, especially in light of the abortion debate. Ultimately, the book demonstrates the role that the pharmaceutical industry plays in shaping drug policy that has far-reaching social and political consequences, balancing scientific and medical advancements against government regulation and public opinion.

"synopsis" may belong to another edition of this title.

Other Popular Editions of the Same Title